Influenza, Human  >>  amantadine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
amantadine / Generic mfg.
Combina, NCT00830323 / 2008-004543-11: Efficacy and Safety of tion Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection

Terminated
2
60
Europe
oseltamivir + zanamivir, oseltamivir+ amantadine, oseltamivir
Hospices Civils de Lyon
Influenza A Infection
08/09
08/09
PO206, NCT00979251 / 2009-015850-39: Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects

Completed
2
2
US, Canada, Europe, RoW
Oseltamivir Phosphate, Tamiflu, ADS-8902, Amantadine Hydrochloride, Rebetol®, Tamiflu®
Adamas Pharmaceuticals, Inc.
Influenza
05/10
08/11
IRC003, NCT01227967: Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications

Completed
2
881
US, RoW
Amantadine, Ribavirin, Oseltamivir, Oseltamivir
National Institute of Allergy and Infectious Diseases (NIAID)
Influenza
05/16
03/17
NCT00867139: TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients

Completed
1/2
7
US
TCAD, Symmetrel, Rebetol, Tamiflu, Zanamivir or Oseltamivir, Relenza, Open label treatment with TCAD
Fred Hutchinson Cancer Center
Influenza
08/09
01/10

Download Options